The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. (Q35675023)

9 August 2017

1 reference

title

The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. (English)

1 reference

sexually transmitted infection

9 August 2017

0 references

0 references

author name string

Harrell W Chesson

1

1 reference

9 August 2017

John M Blandford

2

1 reference

9 August 2017

Thomas L Gift

3

1 reference

9 August 2017

Guoyu Tao

4

1 reference

9 August 2017

Kathleen L Irwin

5

1 reference

9 August 2017

publication date

1 January 2004

1 reference

Perspectives on Sexual and Reproductive Health

9 August 2017

published in

1 reference

9 August 2017

volume

36

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

11-19

1 reference

Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000

9 August 2017

cites work

1 reference

Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization

21 January 2018

1 reference

Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs

21 January 2018

1 reference

Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy

21 January 2018

1 reference

Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy

21 January 2018

1 reference

Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance

21 January 2018

1 reference

External genital warts: diagnosis, treatment, and prevention.

21 January 2018

1 reference

The cost of treating genital warts

21 January 2018

1 reference

Medical care expenditures for genital herpes in the United States

21 January 2018

1 reference

Incidence of herpes simplex virus type 2 infection in the United States

21 January 2018

1 reference

Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States

21 January 2018

1 reference

Is the routine pelvic examination needed with the advent of urine-based screening for sexually transmitted diseases?

21 January 2018

1 reference

Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays

21 January 2018

1 reference

Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay

21 January 2018

1 reference

The clinical and economic consequences of screening young men for genital chlamydial infection

21 January 2018

1 reference

Silent upper genital tract chlamydial infection and disease in women

21 January 2018

1 reference

Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease

21 January 2018

1 reference

Patterns of Chlamydia trachomatis testing and follow-up at a University Hospital Medical Center

21 January 2018

1 reference

A refined estimate of the average lifetime cost of pelvic inflammatory disease

21 January 2018

1 reference

Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy

21 January 2018

1 reference

Management of urethritis in health maintenance organization members receiving care at a multispecialty group practice in Massachusetts

21 January 2018

1 reference

Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions

21 January 2018

1 reference

Predicting 10-year care requirements for older people with suspected Alzheimer's disease

21 January 2018

1 reference

Sexually transmitted diseases and the increased risk for HIV transmission: implications for cost-effectiveness analyses of sexually transmitted disease prevention interventions

21 January 2018

1 reference

21 January 2018

Epidemiological Synergy

1 reference

21 January 2018

Identifiers

DOI

10.1363/3601104

1 reference

release_lg6fxsjwpvdnrni73mof7rlc4a

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lg6fxsjwpvdnrni73mof7rlc4a

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference